论文部分内容阅读
目的研究胰十二指肠合并肠系膜上静脉-门静脉切除的手术安全性及术后生存率。方法回顾性分析25例因胰腺癌行胰十二指肠合并肠系膜上静脉-门静脉切除病人,根据病理有无真正的血管侵犯分为A、B两组,A组:无真正的血管侵犯,B组:肠系膜上静脉-门静脉侵犯。结果25例胰十二指肠合并肠系膜上静脉-门静脉切除并发症发生率为32.0%,无一例手术死亡,术后1、2年生存率分别为56.0%、28.0%,A、B两组并发症发生率、术后2年生存率无明显差别。结论肠系膜上静脉-门静脉侵犯并非胰腺癌根治术的禁忌证,只要仔细选择病例,合并肠系膜上静脉-门静脉切除可安全施行,并不增加手术并发症和死亡率。
Objective To study the operative safety and postoperative survival rate of pancreaticoduodenal mesenteric vein-portal vein resection. Methods A retrospective analysis of 25 patients with pancreaticoduodenectomy combined with superior mesenteric vein - portal vein resection patients were divided into A and B groups according to the presence or absence of true vascular invasion. Group A: no real vascular invasion, B Group: Superior mesenteric vein - portal vein invasion. Results The incidence of complications in 25 cases of pancreaticoduodenal combined with superior mesenteric vein-portal vein was 32.0%, and none of them died. The 1-year and 2-year survival rates were 56.0% and 28.0% respectively. A and B were complicated by complications Disease incidence, 2-year survival rate no significant difference. Conclusions The superior mesenteric vein-portal vein invasion is not a contraindication to radical resection of the pancreas. As long as careful selection of the cases, the superior mesenteric vein-portal vein resection can be safely performed without increasing the complications and mortality.